The global Blood Screening Pregnancy Market size was USD 2.50 Billion in 2021 and is expected to register a revenue CAGR of 8.4% over the forecast period, according to the latest report by Reports and Data. Market revenue growth is primarily driven by development of new methods for detecting bloodstream pathogens. In addition, rising prevalence of new pathogens, increasing public health awareness, rising number of blood donations, and surge in Nucleic Acid Amplification Testing (NAT) are other factors driving revenue growth of the market. Pathogen inactivation is an active strategy to inactivate pathogens before they enter the blood supply. Vast majority of pathogen inactivation techniques concentrate on nucleic acids and allow for inactivation of a wide range of pathogens including nucleic acids in plasma, platelets, or red blood cells, potentially lowering risk of sickness associated with transfusion. Blood transfusions save lives and improve health, but many patients who need them do not have timely access to safe blood. In addition, strict government rules and regulations in each country for provision of safe and adequate blood are expected to facilitate adoption of blood testing in blood banks and medical facilities. Moreover, WHO also recommends that all activities related to collection, testing, processing, storage, and distribution of blood should be coordinated at the national level through effective organizations and integrated blood supply networks. Furthermore, national blood system is governed by a national blood policy and legal framework to promote uniformity and consistent implementation of standards in the quality and safety of blood and blood products. These factors are expected to drive market revenue growth.

Request a sample Report of Blood Screening Pregnancy Market @ https://www.reportsanddata.com/download-free-sample/3458

Some Key Highlights From the Report

  • The reagents & kits segment is expected to register a rapid revenue growth rate during the forecast period owing to increasing need for specific, reliable, and fast detection of Blood Screening Pregnancy. Most Blood Screening Pregnancy tests use reagents, which are substances or compounds that can accelerate testing procedures including pregnancy tests, blood sugar tests, and other Blood Screening Pregnancy. Reagents are also commonly used to test for the presence of certain substances in blood. This is because binding of reagents to substances or other related substances causes specific reactions to detect presence of another substance.
  • The NAT segment is expected to lead in terms of revenue over the forecast period owing to increasing need for screening blood donations to reduce risk of Transfusion-Transmitted Infections (TTIs). NAT method is fairly accurate and targets viral nucleic acids. A form of molecular screening method called NAT is used in blood donations and other situations to screen blood and lower risk of Transfusion infections (TTIs) in the recipient of blood. In addition, important use of nucleic acid testing is for identification of viral RNA and DNA in blood samples.
  • The blood banks segment is expected to register a steady revenue growth rate during forecast period owing to growing number of organ transplantation surgeries. Rising prevalence of transfusion-transmissible illnesses, such as HIV, hepatitis B, hepatitis C, and syphilis, is also expected to drive revenue growth of this segment. There is a global demand for clean and readily available blood owing to risk of spreading deadly diseases, such as HIV and hepatitis, through contaminated blood as well as persistent blood shortages, which further drives demand for Blood Screening Pregnancy procedures.
  • The Asia Pacific market is expected to account for largest revenue share in the global market during the forecast period owing to rising prevalence of HIV, kidney, heart, and bacterial diseases in countries such as India and China. There are over 7.8 million people with chronic renal disease in India. Covid-19 pandemic and increased government and private business efforts to boost public confidence and knowledge are also driving market growth. Furthermore, rise in cardiovascular diseases and changes in lifestyle are other factors driving market revenue growth.

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/3458

Key Players covered in this report are

Abbott, GE Healthcare, F. Hoffmann-La Roche Ltd., Grifols, S.A., Thermo Fisher Scientific, Inc., Procter & Gamble, Ortho Clinical Diagnostics, Inc., Bio-Rad Laboratories, Inc., Enzo Biochem, Inc., and Danaher.

Product and Service Outlook (Revenue, USD Billion; 2019–2030)

  • Reagents & Kits
  • NAT Reagents & Kits
    • Standards and Controls
    • Buffers, Nucleotides, and Solutions
    • Enzymes and Polymerases
    • Probes and Primers
    • Labeling and Detection Reagents
  • ELISA Reagents & Kits
    • Controls
    • Substrates
    • Immunosorbents
    • Conjugates
    • Sample Diluents and Wash Solutions
  • Instruments
    • Rental Purchase
    • Outright Purchase
  • Software and Services

Technology Outlook (Revenue, USD Billion; 2019–2030)

  • ELISA
    • Fluorescent Immunoassay
    • Chemiluminescent Immunoassay
    • Colorimetric Immunoassay
  • NAT
    • Transcription-Mediated Amplification
    • Real-time Polymerase Chain Reaction
  • Western Blot Assays
  • Rapid Tests
  • Next-generation Sequencing

End-user Outlook (Revenue, USD Billion; 2019–2030)

  • Hospitals
  • Blood Banks

Based on Region market is segmented into:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Major Points covered in this report are as below:

  • An analysis of Blood Screening Pregnancy industry development trends and marketing channels, as well as an assessment of the feasibility of new investment projects, is presented in the study.
  • In addition to providing key statistics on the industry, the report provides valuable guidance and direction for companies and individuals interested in this market through tables and figures.
  • In addition to developing policies and plans, this report analyzes manufacturing processes and cost structures. It also provides information about import/export demand, costs, prices, revenues, and gross margins.
  • This report provides information on the market status of Blood Screening Pregnancy manufacturers and provides valuable insight into the market for companies and individuals.

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

Ask For customization of Report @ https://www.reportsanddata.com/request-customization-form/3458

This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.

Explore More Industry Research by Reports and Data:

Aesthetic Medicine Market @ https://www.biospace.com/article/aesthetic-medicine-market-growth-2022-2030-rising-adoption-of-minimally-invasive-and-non-invasive-treatment/

Surgical Table Market @ https://www.biospace.com/article/surgical-table-market-size-2022-2030-rising-demand-for-surgeries-worldwide-and-an-increase-in-demand-for-technologically-advanced-surgical-tables/

Cancer Biomarkers Market @ https://www.biospace.com/article/cancer-biomarkers-market-demand-2022-2030-rise-in-number-of-cancer-patients-has-led-to-rise-in-investments-from-government-to-establish-specialized-hospitals/

Injectable Drug Delivery Market @ https://www.biospace.com/article/injectable-drug-delivery-market-demand-2022-2030-increased-use-of-contraceptive-injectable-is-a-key-factor-driving-revenue-growth-of-the-industry/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com